CCR5 Mutations Distinguish N-Terminal Modifications of RANTES (CCL5) with Agonist versus Antagonist Activity

ABSTRACT CCR5 is the major HIV-1 entry coreceptor. RANTES/CCL5 analogs are more potent inhibitors of infection than native chemokines; one class activates and internalizes CCR5, one neither activates nor internalizes, and a third partially internalizes without activation. Here we show that mutations in CCR5 transmembrane domains differentially impact the activity of these three inhibitor classes, suggesting that the transmembrane region of CCR5, a key interaction site for inhibitors, is a sensitive molecular switch, modulating receptor activity.

[1]  S. O. Smith,et al.  A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Oliver Hartley,et al.  Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Lederman,et al.  Prevention of Vaginal SHIV Transmission in Rhesus Macaques Through Inhibition of CCR5 , 2004, Science.

[4]  E. Kellenberger,et al.  AN ALLOSTERIC MODEL OF MARAVIROC BINDING TO CCR 5 , 2011 .

[5]  Esther Kellenberger,et al.  New Insights into the Mechanisms whereby Low Molecular Weight CCR5 Ligands Inhibit HIV-1 Infection* , 2010, The Journal of Biological Chemistry.

[6]  R. Connor,et al.  Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. , 1995, Virology.

[7]  T. Frimurer,et al.  Allosteric and Orthosteric Sites in CC Chemokine Receptor (CCR5), a Chimeric Receptor Approach* , 2011, The Journal of Biological Chemistry.

[8]  E. Kellenberger,et al.  Allosteric Model of Maraviroc Binding to CC Chemokine Receptor 5 (CCR5)* , 2011, The Journal of Biological Chemistry.

[9]  Hui-yu Liu,et al.  An Orphan G Protein-Coupled Receptor, GPR1, Acts as a Coreceptor To Allow Replication of Human Immunodeficiency Virus Types 1 and 2 in Brain-Derived Cells , 1999, Journal of Virology.

[10]  Shoshana J. Wodak,et al.  The TXP Motif in the Second Transmembrane Helix of CCR5 , 2001, The Journal of Biological Chemistry.

[11]  M. Goldsmith,et al.  Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Shoshana J. Wodak,et al.  Activation of CCR5 by Chemokines Involves an Aromatic Cluster between Transmembrane Helices 2 and 3* , 2003, The Journal of Biological Chemistry.

[13]  R. Offord,et al.  Highly potent, fully recombinant anti-HIV chemokines: Reengineering a low-cost microbicide , 2008, Proceedings of the National Academy of Sciences.

[14]  J. Mullins,et al.  Evolution of CCR5 Use before and during Coreceptor Switching , 2008, Journal of Virology.

[15]  Marc Parmentier,et al.  The Core Domain of Chemokines Binds CCR5 Extracellular Domains while Their Amino Terminus Interacts with the Transmembrane Helix Bundle* , 2003, The Journal of Biological Chemistry.

[16]  Yasushi Tojo,et al.  Structural and Molecular Interactions of CCR5 Inhibitors with CCR5* , 2006, Journal of Biological Chemistry.

[17]  Anandan Palani,et al.  Interaction of small molecule inhibitors of HIV-1 entry with CCR5. , 2006, Virology.